Opendata, web and dolomites

SAFE-CAB SIGNED

Laser-Assisted Surgical System to Revolutionize Cardiac Bypass Surgeries

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 SAFE-CAB project word cloud

Explore the words cloud of the SAFE-CAB project. It provides you a very rough idea of what is the project "SAFE-CAB" about.

flow    arresting    invasive    reduce    patients    opportunity    deutsches    sme    entry    procedure    surgeons    safe    obtain    arrested    amt    catheter    prevent    replacing    solutions    dutch    surgeries    readiness    suturing    times    kit    shorter    proprietary    replace    group    substantially    standard    performed    annual    rates    health    survival    cardiac    treat    lifetec    care    company    training    herzzentrum    outcomes    hemex    seeking    disease    berlin    organisation    containing    15    heart    translates    society    risk    thereby    surgery    regulatory    cardiovascular    realize    infarction    first    severe    patient    blood    beating    myocardial    hospital    recovery    bypass    clinical    laser    vision    lt    endovascular    pan    192m    device    minimally    technically    professional    oldest    700    annually    medical    89m    attack    validation    complications    extremely    complemented    artery    final    implant    surgical    coronary       cab    gt    chest    approval    accelerate    assisted    market    closed   

Project "SAFE-CAB" data sheet

The following table provides information about the project.

Coordinator
AMT MEDICAL RESEARCH BV 

Organization address
address: YALELAAN 52
city: UTRECHT
postcode: 3584 CM
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Netherlands [NL]
 Total cost 2˙850˙312 €
 EC max contribution 2˙182˙118 € (77%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-EIC-FTI-2018-2020
 Funding Scheme IA
 Starting year 2019
 Duration (year-month-day) from 2019-09-01   to  2022-02-28

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    AMT MEDICAL RESEARCH BV NL (UTRECHT) coordinator 397˙250.00
2    HEMEX AG CH (LIESTAL) participant 903˙875.00
3    DEUTSCHES HERZZENTRUM BERLIN DE (BERLIN) participant 432˙625.00
4    LIFETEC GROUP BV NL (EINDHOVEN) participant 257˙993.00
5    EUROPEAN SOCIETY FOR CARDIOVASCULAR AND ENDOVASCULAR SURGERY CH (ZURICH) participant 190˙375.00

Map

 Project objective

Coronary Artery Bypass (CAB) surgery is performed annually in >700,000 patients to treat coronary artery disease and prevent myocardial infarction (heart attack). Standard CAB surgery involves a highly invasive open-heart procedure in arrested/non-beating heart, that is associated with long recovery times and severe complications. The surgeons are seeking for less invasive, closed chest CAB procedures on beating heart, but current solutions are technically extremely challenging and thereby only used in <1-3% of all surgeries. The vision of the SAFE-CAB consortium is to make the minimally invasive CAB surgeries available to all surgeons as a novel standard of care, thereby substantially improve patient outcomes and reduce health care costs. The goal of the project is to bring to market a first-of-its-kind laser-assisted minimally invasive surgical system (surgical kit containing surgical implant and laser catheter). SAFE-CAB enables minimally invasive procedure on beating heart, without the need for arresting blood flow or complex hand suturing. With shorter recovery times, less complications and improved survival rates in high-risk patients, the SAFE-CAB technology has a potential to replace high-risk open-heart surgeries. Replacing only 15% of open-heart surgeries in Europe and US translates to annual market opportunity of >€89M and >€192M. Dutch SME AMT Medical has developed the proprietary SAFE-CAB technology to clinical readiness. To substantially accelerate the market entry of the product, the company partners with a leading European cardiac surgery hospital Deutsches Herzzentrum Berlin and a pan-European clinical/regulatory medical device company HEMEX to obtain regulatory approval through final clinical validation . To realize European wide-implementation, the consortium is complemented by a surgery training company LifeTec Group and the oldest professional organisation for cardiac surgeons European Society of CardioVascular and Endovascular Surgery.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SAFE-CAB" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SAFE-CAB" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.1.)

GoSafe (2019)

Restoring complete sensory ability for natural walking of amputees

Read More  

PATH-TOX (2018)

Artificial Intelligence to transform Drug and Chemical safety testing

Read More  

GIoT (2019)

Nano-satellites based Global Infrastructure to Enable IoT/M2M Networks - GIoT (Global IoT)

Read More